Nexeon MedSystems Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Nexeon MedSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014238
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery systems, and cell delivery and regenerative therapy devices in various stages of development. It develops anatomy-specific combination embolic protection and stent delivery systems for endovascular procedures. The company develops cell delivery and regenerative therapies for delivery of stem cells and biologics to target end-organ sites in order to treat conditions such as chronic congestive heart failure, chronic critical limb ischemia and acute myocardial infarction. Nexeon is headquartered in Dallas, Texas, the US.

Nexeon MedSystems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nexeon MedSystems Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Nexeon Medsystems Raises Private Round of Funding 11
Nexeon MedSystems Raises USD1.3 Million in Financing 12
Equity Offering 13
Nexeon MedSystems to Raise Funds in Private Placement of Shares 13
Nexeon MedSystems Inc – Key Competitors 14
Nexeon MedSystems Inc – Key Employees 15
Nexeon MedSystems Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Sep 28, 2017: Nexeon MedSystems Begins Trading as NXNN 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nexeon MedSystems Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Nexeon MedSystems Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nexeon MedSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nexeon Medsystems Raises Private Round of Funding 11
Nexeon MedSystems Raises USD1.3 Million in Financing 12
Nexeon MedSystems to Raise Funds in Private Placement of Shares 13
Nexeon MedSystems Inc, Key Competitors 14
Nexeon MedSystems Inc, Key Employees 15
Nexeon MedSystems Inc, Subsidiaries 16

★海外企業調査レポート[Nexeon MedSystems Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmAbcine Inc (PharmAbcine) is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers products such as bi-specific MAB and lead MAB products. It provides services such as binding test by ELISA, screening by ELISA, mono-phage Ab seque …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Assembly Biosciences Inc (ASMB)-製薬・医療分野:企業M&A・提携分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus (HBV) and microbioti …
  • Campbell Soup Co (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Co (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AusGroup Ltd (5GJ):石油・ガス:M&Aディール及び事業提携情報
    Summary AusGroup Ltd (AusGroup) is a provider of project and asset services. The company operates through its subsidiaries, namely, MAS, AGC, and NT Port and Marine. Its major services include mechanical and piping, scaffolding, multidisciplinary maintenance services, fabrication & management, surfa …
  • Allianz Global Assistance SAS:企業の戦略・SWOT・財務情報
    Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Diamond Offshore Drilling Inc (DO):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ecrins Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company offers products such as native and labeled tubulin, tubulin polymerization kit, monoclonal a …
  • Banco del Pichincha C.A.:企業の戦略・SWOT・財務情報
    Banco del Pichincha C.A. - Strategy, SWOT and Corporate Finance Report Summary Banco del Pichincha C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Saponia D.D.:企業の戦略・SWOT・財務分析
    Saponia D.D. - Strategy, SWOT and Corporate Finance Report Summary Saponia D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Magnolia Petroleum Plc (MAGP):企業の財務・戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Himatsingka Seide Ltd:企業の戦略・SWOT・財務情報
    Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report Summary Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Overseas Land & Investment Limited:企業の戦略・SWOT・財務情報
    China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report Summary China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Torraspapel, S.A.:企業の戦略的SWOT分析
    Torraspapel, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Euskaltel SA (EKT):企業の財務・戦略的SWOT分析
    Euskaltel SA (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Deutsche Wohnen AG:企業のM&A・事業提携・投資動向
    Deutsche Wohnen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Wohnen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆